The Indian pharmaceutical industry that supplies nearly 47% of generic medicines to the US is also under scrutiny. The proposed reciprocal tariffs on pharmaceuticals could disrupt a sector that has played a key role in providing affordable medicines. However, experts largely negated any significant impact on the sector due the mutual dependence of both countries.